Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01772732 |
Recruitment Status : Unknown
Verified April 2015 by Jiangsu Simcere Pharmaceutical Co., Ltd..
Recruitment status was: Recruiting
First Posted : January 21, 2013
Last Update Posted : April 9, 2015
|
Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Jiangsu Simcere Pharmaceutical Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | December 2015 |
Estimated Study Completion Date : | December 2015 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):